37 results on '"Teo, Steve"'
Search Results
2. Safety considerations for dietary supplement manufacturers in the United States
3. Clinical Pharmacokinetics of Thalidomide
4. Thalidomide as a novel therapeutic agent: new uses for an old product
5. Effects of Thalidomide on Developmental, Peri- and Postnatal Function in Female New Zealand White Rabbits and Offspring
6. A Single-Dose, Two-Way Crossover, Bioequivalence Study of Dexmethylphenidate HCl with and without Food in Healthy Subjects
7. Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats
8. Transient increase in plasma HIV-1 viral load and associated weight gain after thalidomide dosing
9. Thalidomide Dose Proportionality Assessment following Single Doses to Healthy Subjects
10. Safety Profile of Thalidomide after 53 Weeks of Oral Administration in Beagle Dogs
11. d-Methylphenidate is non-genotoxic in in vitro and in vivo assays
12. Single-Dose Oral Pharmacokinetics of Three Formulations of Thalidomide in Healthy Male Volunteers
13. Supplemental Material, DS1_VET_10.1177_0192623318789130 - The Antitussive Benzonatate Is Not Tumorigenic in Rodent Carcinogenicity Studies
14. Sensitive and rapid method for the determination of thalidomide in human plasma and semen using solid-phase extraction and liquid chromatography–tandem mass spectrometry
15. The perinatal and postnatal toxicity of d-methylphenidate and d, l-methylphenidate in rats
16. Enantioselective relief of neuropathic pain by systemic mexiletine in the rat
17. The Antitussive Benzonatate Is Not Tumorigenic in Rodent Carcinogenicity Studies
18. Genotoxicity assessment of the novel antitussive agent Benzonatate and its major metabolite
19. Transport Properties of Steroid Glucuronides
20. Effects of thalidomide on reproductive function and early embryonic development in male and female New Zealand white rabbits
21. A 90-Day Oral Gavage Toxicity Study of d-Methylphenidate and d, I-Methylphenidate in Beagle Dogs
22. D-methylphenidate andD,L-methylphenidate are not developmental toxicants in rats and rabbits
23. Chiral inversion of the second generation IMiD™ CC‐4047 (ACTIMID™) in human plasma and phosphate‐buffered saline
24. A 90-day oral gavage toxicity study of d-methylphenidate and d,l-methylphenidate in Sprague–Dawley rats
25. Thalidomide in the treatment of leprosy
26. The perinatal and postnatal toxicity of d-methylphenidate and d,l-methylphenidate in rats
27. Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen?s disease patients
28. Assessment of the in vitro and in vivo genotoxicity of Thalomid� (thalidomide)
29. Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women
30. Subchronic Toxicity of Thalidomide in Rodents After 13 Weeks of Oral Administration
31. Reversal of Heparin Anticoagulation by Recombinant Platelet Factor 4 in Humans
32. Mirex inhibits bile acid secretory function in vivo and in the isolated perfused rat liver
33. Mirex exposure inhibits the uptake of estradiol-17β(β-d-glucuronide), taurocholate, and l-alanine into isolated rat hepatocytes
34. A 90-Day Oral Gavage Toxicity Study of d -Methylphenidate and d , l -Methylphenidate in Beagle Dogs.
35. D‐methylphenidate and D,L‐methylphenidate are not developmental toxicants in rats and rabbits
36. Production of superoxide anion radicals during the oxidative metabolism of aminochloramphenicol
37. Genotoxicity assessment of the novel antitussive agent Benzonatate and its major metabolite.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.